Your Gleason Score Matters | #ProstateCancer #MarkScholzMD #AlexScholz

Your Gleason Score Matters | #ProstateCancer #MarkScholzMD #AlexScholz

Clinical Trial Results: Gleason 6 #ProstateCancer & Targeted Biopsies | #MarkScholzMD #AlexScholzSee more

Clinical Trial Results: Gleason 6 #ProstateCancer & Targeted Biopsies | #MarkScholzMD #AlexScholz

Does #ProstateCancer Tumor Size and Location Matter? | #MarkScholzMD #AlexScholz | #PCRISee more

Does #ProstateCancer Tumor Size and Location Matter? | #MarkScholzMD #AlexScholz | #PCRI

Treating #ProstateCancer In Younger Men | Age 40-60 | #MarkScholzMD #AlexScholz #PCRISee more

Treating #ProstateCancer In Younger Men | Age 40-60 | #MarkScholzMD #AlexScholz #PCRI

Gleason 4+4=8 & Hormone Therapy | Ask a Prostate Cancer Expert, Mark Scholz, MDSee more

Gleason 4+4=8 & Hormone Therapy | Ask a Prostate Cancer Expert, Mark Scholz, MD

#ProstateCancer Diagnosis Over 80 Years Old | #MarkScholzMD #AlexScholz | #PCRISee more

#ProstateCancer Diagnosis Over 80 Years Old | #MarkScholzMD #AlexScholz | #PCRI

The Four Levels of #ProstateCancer Treatment Intensity | #markscholzmd #alexscholz @ThePCRISee more

The Four Levels of #ProstateCancer Treatment Intensity | #markscholzmd #alexscholz @ThePCRI

3+4=7 #ProstateCancer | Active Surveillance vs. Focal Therapy | #MarkScholzMD #AlexScholz #PCRISee more

3+4=7 #ProstateCancer | Active Surveillance vs. Focal Therapy | #MarkScholzMD #AlexScholz #PCRI

Events